(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 17.69% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Astrana Health's revenue in 2025 is $2,896,455,000.On average, 12 Wall Street analysts forecast ASTH's revenue for 2025 to be $184,231,982,295, with the lowest ASTH revenue forecast at $175,507,277,970, and the highest ASTH revenue forecast at $192,731,532,960. On average, 12 Wall Street analysts forecast ASTH's revenue for 2026 to be $234,047,229,570, with the lowest ASTH revenue forecast at $216,372,667,260, and the highest ASTH revenue forecast at $250,145,716,260.
In 2027, ASTH is forecast to generate $257,069,191,305 in revenue, with the lowest revenue forecast at $239,563,494,240 and the highest revenue forecast at $278,402,500,590.